Atlas Trials

Androgen-Resistant Prostatic Neoplasms

1 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Androgen-Resistant Prostatic Neoplasms

RecordFirmDate
Adenosine Receptor Antagonist Combination Therapy for Metastatic Castrate Resistant Prostate Cancer (NCT04381832)Arcus Biosciences, Inc.2020-07-07

Track Androgen-Resistant Prostatic Neoplasms automatically

Every clearance here is in the API, with alerts when new ones post.